Paolo Preziosi

Paolo Preziosi's AcademicInfluence.com Rankings

Paolo Preziosi

Biology

#12823

World Rank

#16326

Historical Rank

Neuroscience

#2182

World Rank

#2243

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Paolo Preziosi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paolo Preziosi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

M Channels Containing KCNQ2 Subunits Modulate Norepinephrine, Aspartate, and GABA Release from Hippocampal Nerve Terminals (2004) (167)
[Chronic cor pulmonale]. (1952) (131)
Isoniazid: metabolic aspects and toxicological correlates. (2007) (124)
Dietary patterns in six European populations: results from EURALIM, a collaborative European data harmonization and information campaign (2000) (118)
Erythropoietin exerts anti‐apoptotic effects on rat microglial cells in vitro (2002) (115)
Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic–pituitary–adrenal axis (2010) (104)
Obesity and other health determinants across Europe: The EURALIM Project (2000) (86)
Carbon monoxide as a novel neuroendocrine modulator: inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants. (1994) (86)
Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. (2011) (84)
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment. (2011) (82)
Enhancement patterns of prostate cancer in dynamic MRI (2003) (78)
Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine. (2012) (77)
Hydroxyurea: new insights on an old drug. (1999) (76)
Bilirubin as an endogenous modulator of neurotrophin redox signaling (2008) (73)
Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro (2012) (70)
Involvement of nitric oxide in basal and interleukin-1 beta-induced CRH and ACTH release in vitro. (1993) (62)
Anaphylaxis increases 8-iso-prostaglandin F2alpha release from guinea-pig lung in vitro. (1999) (60)
Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkage between heme catabolism and neuroendocrine function. (1997) (60)
Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat (1999) (57)
Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypothalamic explants and in primary cultures of rat hypothalamic astrocytes. (1997) (55)
The role of central noradrenergic neurons in the control of thyrotropin secretion in the rat. (1977) (55)
Evidence for central norepinephrine-mediated inhibition of ACTH secretion in the rat. (1972) (54)
Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre‐synaptic muscarinic receptor activation from rat striatal synaptosomes (2007) (53)
The role of carbon monoxide in the regulation of neuroendocrine function. (1997) (53)
Endocrine disrupters as environmental signallers: an introduction (1998) (50)
Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario? (2004) (48)
Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before (2011) (47)
Gaseous Neuromodulators in the Control of Neuroendocrine Stress Axis (2000) (45)
The Generation of Nitric Oxide and Carbon Monoxide Produces Opposite Effects on the Release of Immunoreactive Interleukin-1β from the Rat Hypothalamus in Vitro: Evidence for the Involvement of Different Signaling Pathways. (1998) (45)
Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor kappaB. (1999) (44)
Characterization of the S-denitrosylating activity of bilirubin. (2009) (42)
Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine andd-fenfluramine in rats (1979) (42)
Adrenocortical suppression and other endocrine effects of etomidate. (1988) (41)
Role of brain norepinephrine and serotonin in the tonic and phasic regulation of hypothalamic hypophyseal adrenal axis. (1972) (39)
On the pharmacology of synthetic hypertensine. (1960) (38)
Serotonin control of prolactin release: an intriguing puzzle (1983) (38)
Evidence for the neuronal origin of immunoreactive interleukin-1β released by rat hypothalamic explants (1996) (37)
Brain monoamines and adrenocortical activation (1969) (36)
Vasoactive Intestinal Peptide and Forskolin Stimulate Interleukin 6 Production by Rat Cortical Astrocytes in Culture via a Cyclic AMP‐Dependent, Prostaglandin‐Independent Mechanism (1994) (36)
Nitric oxide synthase activity and non‐adrenergic non‐cholinergic relaxation in the rat gastric fundus (1996) (34)
Non-adrenergic non-cholinergic relaxation of the rat stomach. (1998) (32)
Chromaffin cells: the peripheral brain (2012) (32)
Ultrastructure of the testis in rats with blood hypertension induced by long-term lead exposure. (1988) (32)
Neurotransmitters of the non-adrenergic non-cholinergic relaxation of proximal stomach. (2008) (32)
The release of immunoreactive interleukin-1 beta from rat hypothalamic explants is modulated by neurotransmitters and corticotropin-releasing hormone. (1997) (29)
Etomidate and corticotrophic axis. (1982) (28)
Influence of restraint stress, corticosterone and betamethasone on brain amine levels (1969) (28)
Evidence that interleukin-1 beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway. (1994) (28)
Characterization of the S‐denitrosylating activity of bilirubin (2009) (28)
Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus (2006) (26)
The relative contribution of constitutive and inducible cyclooxygenase activity to lipopolysaccharide-induced prostaglandin production by primary cultures of rat hypothalamic astrocytes (1998) (26)
A possible role for nitric oxide but not for prostaglandin E2 in basal and interleukin-1-beta-induced PRL release in vitro. (1995) (26)
Percutaneous antegrade transarterial treatment of iatrogenic radial arteriovenous fistula. (2012) (26)
Age-Related Different Relationships between Ectopic Adipose Tissues and Measures of Central Obesity in Sedentary Subjects (2014) (26)
Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 alpha and lack of effect of nerve growth factor. (1994) (26)
The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon. (1992) (25)
Effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, mCPP. (1983) (25)
Inhibition by Anandamide and Synthetic Cannabimimetics of the Release of [3H]d-Aspartate and [3H]GABA from Synaptosomes Isolated from the Rat Hippocampus (2004) (24)
Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis (2005) (24)
Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission. (2004) (23)
Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron (2018) (22)
HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase (2001) (21)
The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1beta from the rat hypothalamus in vitro: evidence for the involvement of different signaling pathways. (1998) (20)
Effect of 6-hydroxydopamine treatment on TSH secretion in basal and cold-stimulated conditions in the rat. (1979) (20)
Effect of selective lesioning of serotonin-containing neurons on the TSH-inhibiting action of d-fenfluramine in male rats. (1979) (20)
Hydroxyurea: relationship between toxicity and centrally-induced adrenal activation. (1990) (20)
Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase (2004) (19)
Evidence that the interleukin-1β-induced prostaglandin E2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors (1995) (19)
[Biological transformation of isonicotinic acid hydrazide]. (1954) (19)
Effect of selective degeneration of brain serotonin-containing neurons on plasma corticosterone levels: studies with d-fenfluramine. (1979) (18)
Effect of quipazine and D-fenfluramine, two serotonin-like drugs, on TSH secretion in basal and cold stimulated conditions in the rat. (1978) (17)
Prenatal Diazepam Exposure Functionally Alters the GABAA Receptor That Modulates [3H]Noradrenaline Release from Rat Hippocampal Synaptosomes (2002) (17)
Cardiac magnetic resonance detection of left ventricular thrombus in acute myocardial infarction (2013) (17)
Prostaglandin E2 and bacterial lipopolysaccharide stimulate bioactive interleukin-1 release from rat hypothalamic explants. (1993) (17)
Electrophysiological studies of the effects of the general anaesthetic etomidate on frog myelinated nerve fibre (1987) (17)
Receptor involvement in the central noradrenergic inhibition of ACTH secretion in the rat. (1973) (17)
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain (2009) (17)
Interaction of Formamidine Pesticides with the Presynaptic α2-Adrenoceptor Regulating [3H]Noradrenaline Release from Rat Hypothalamic Synaptosomes (2001) (17)
Interleukin-1 in the central nervous system: from physiology to pathology. (2000) (17)
Evidence for an apamin‐sensitive, but not purinergic, component in the nonadrenergic noncholinergic relaxation of the rat gastric fundus (2004) (17)
Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals (1984) (17)
Effects of nitric oxide donors on basal and K+-evoked release of [3H]noradrenaline from rat cerebral cortex synaptosomes. (1998) (16)
Involvement of vasoactive intestinal polypeptide in nicotine‐induced relaxation of the rat gastric fundus (1997) (16)
Interleukin-1 beta specifically stimulates nitric oxide production in the hypothalamus. (1996) (16)
Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay. (1989) (16)
Chronic depletion of brain catecholamines and thyrotropin secretion in the rat. (1977) (16)
Interleukin-1α and tumour necrosis factor inhibit rat gastric fundus motility in vitro (1993) (15)
Biosynthesis of endothelium-derived nitric oxide by bradykinin as endogenous precursor. (1996) (15)
Bacterial lipopolysaccharide increases interleukin-6 and prostaglandin release in rat cortical type I astrocytes by different mechanisms: role of anti-inflammatory agents. (1998) (15)
Renal ultrastructural alterations and cardiovascular functional changes in rats exposed to mercuric chloride. (1989) (15)
Pharmacological depletion of adrenaline and noradrenaline in various organs of mice. (1959) (15)
Contraceptives, brain serotonin, and liver tryptophan pyrrolase. (1970) (14)
Time-course of the effect of α-methyl-p-tyrosine on acth secretion (1975) (14)
Effects of lipopolysaccharide on hypothalamic-pituitary-adrenal axis in vitro. (1994) (14)
A functional link between heme oxygenase and cyclo-oxygenase activities in cortical rat astrocytes. (2001) (14)
Hydroxyurea induces the gene expression and synthesis of proinflammatory cytokines in vivo. (1997) (14)
EFFECTS OF PACLOBUTRAZOL (PP333) ON NURSERY TREES OF OLIVE (1986) (13)
Peptide histidine isoleucine‐like immunoreactivity release from the rat gastric fundus (1994) (13)
ETOMIDATE, SEDATIVES, AND NEUROENDOCRINE CHANGES (1983) (13)
Brain and liver tryptophan pathways and adrenocortical activation during restraint stress (1969) (13)
K+‐evoked [3H]D‐aspartate release in rat spinal cord synaptosomes: Modulation by neuropeptide Y and calcium channel antagonists (2000) (13)
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells (2000) (13)
Influenza pharmacotherapy: present situation, strategies and hopes (2011) (13)
Effects of althesin and ketamine on resting and stress stimulated adrenocortical activity in rats. (1978) (13)
Different regulation of serotonin receptors following adrenal hormone imbalance in the rat hippocampus and hypothalamus (2005) (13)
Cytokines and eicosanoids in cancer drug toxicity. (1992) (12)
Long-term treatment with clonidine and α-receptors in the brain of Normotensive rats (1984) (12)
Cardiovascular system and kidney as specific targets of chronic exposure to vanadate in the rat: functional and morphological findings. (1991) (12)
Role of brain noradrenaline in the tonic regulation of hypothalamic hypophyseal adrenal axis. (1973) (12)
Lack of evidence for an inhibitory role played by tuberoinfundibular dopaminergic neurons on TSH secretion in the rat. (1979) (12)
Carbamazepine, phenytoin and phenobarbital do not influence brain catecholamine uptake, in vivo, in male rats. (1981) (12)
Brain serotonin depletors and adrenocortical activation. (1968) (12)
Regulation of interleukin 6 production by cAMP-protein kinase-A pathway in rat cortical astrocytes. (1994) (12)
Galanin increases potassium evoked release of [3H]5-hydroxytryptamine from rat hypothalamic synaptosomal preparations (1991) (11)
COMPARISON OF THE VEGETATIVE AND REPRODUCTIVE CHARACTERISTICS OF TRADITIONAL OLIVE CULTIVARS AND SELECTED LOW VIGOROUS ACCESSIONS IN CENTRAL ITALY (1994) (11)
Hypothalamic interleukin-1 in physiology and pathology. (1998) (11)
On the pharmacology of chlorothiazide, with special regard to its diuretic and anti-hypertensive effects. (1959) (10)
Effect of dihydroxyphenylserine on the increase in plasma corticosterone in rats treated with alpha-methyl-p-tyrosine. (1973) (10)
Involvement of peptide histidine isoleucine in non-adrenergic non-cholinergic relaxation of the rat gastric fundus induced by high-frequency neuronal firing (2002) (10)
Right varicocele associated with inferior vena cava malformation in situs inversus: percutaneous treatment with retrograde sclerotherapy. (2001) (10)
Prognostic CMR parameters for heart failure and arrhythmias in large cohort of well treated thalssemia major patients (2013) (9)
Circulating Interleukin-1-Beta Levels after Acute and Prolonged Exposure to Low Temperatures: Human and Rat Studies (2000) (9)
Characterization of Ca2+-Channels Responsible for K+-Evoked [3H]Noradrenaline Release from Rat Brain Cortex Synaptosomes and Their Response to Amyotrophic Lateral Sclerosis IgGs (1999) (9)
Tolerance to pituitary-adrenal axis activation by anticancer drugs in normal and tumour-bearing rats. (1984) (9)
Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype (2016) (9)
No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with β-blockers (1999) (9)
Pharmacological properties of 1, 4 dicaffeylquinic acid, the active principle of Cynara scolimus. (1958) (9)
Acid rain: effects on arachidonic acid metabolism in perfused and ventilated guinea-pig lung. (1987) (9)
Rat brain α2‐pre‐ and postsynaptic receptors are different or differently modulated? (1985) (8)
Interleukin-1 beta- and tumour-necrosis-factor-induced inhibition of rat gastric fundus motility in vitro. (1994) (8)
[On the mechanism of the antihypertensive effect of hydrochlorothiazide]. (1960) (8)
Action of dimethylsulfoxide on acute inflammatory reactions. (1966) (8)
Brain neurotransmitters regulating TRH producing neurons. (1981) (8)
A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon. (1992) (8)
Metabolic changes in depression. (1969) (8)
Systemic administration of cocaine, given alone or in combination with sensory stimuli, differentially affects l-arginine-nitric oxide metabolism in discrete regions of the brain of rat (1999) (8)
Tachykinin-eicosanoid crosstalk in airway inflammation. (2000) (8)
Chronic treatment with reserpine and adrenocortical activation. (1976) (8)
Increased plasma corticosterone and decreased plasma thyroid-stimulating hormone levels in rats treated with vincristine. (1977) (8)
Urinary adrenaline and noradrenaline output after medullo-adrenalectomy in dogs. (1959) (7)
Interaction of formamidine pesticides with the presynaptic alpha(2)-adrenoceptor regulating. (2001) (7)
Perfused and ventilated guinea-pig lung: a method for evaluating xenobiotic effects on arachidonic acid using formaldehyde. (1986) (7)
Cardiovascular Actions of Lead in Rats as Related to the Level of Chronic Exposure (1988) (7)
Involvement of peptide histidine isoleucine in non-adrenergic non-cholinergic relaxation of the rat gastric fundus induced by high-frequency neuronal firing (2002) (7)
On the mechanism of the anti-hypertensive effect of hydrochlorothiazide. (1961) (7)
K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists. (2000) (7)
Comparison of choleretic effects of CYN and Na-dehydrocholate (1959) (7)
Antitumour drug toxicity in pituitary or adrenal-ablated rats. (1984) (7)
Behavioural, electrocortical and body temperature effects of cholera toxin. (1976) (6)
Interleukin-1 beta release from rat gastric fundus. (1996) (6)
Depolarization and a NO-donor stimulate interleukin-1β release from the rat hypothalamus via a mechanism involving caspase 1 (1999) (6)
Hepatic hemangiomas on 33 patients. Evaluation by ultrasound, nuclear medicine, computed tomography and angiography. (1983) (6)
Neuropeptide Y enhances the inhibitory effects of clonidine on3H-noradrenaline release in synaptosomes isolated from the medulla oblongata of the male rat (2005) (6)
Brain monoamines and stimulation or inhibition of ACTH release. (1969) (6)
Preliminary observations of some maturity parameters of drupes on 39 Italian olive cultivars. (1990) (6)
Pharmacological actions on the anaphylactic isolated guinea pig lung. (1959) (6)
Serotonergic and endogenous opiates interplay in the control of ACTH and prolactin release. (1983) (5)
FRUIT CHARACTERISTICS OF OLIVE CULTIVARS OF DIFFERENT ORIGIN GROWN IN UMBRIA (1994) (5)
Neurosteroid modulation of the presynaptic NMDA receptors regulating hippocampal noradrenaline release in normal rats and those exposed prenatally to diazepam (2003) (5)
α 2-Adrenoceptor blocking properties of idazoxan stereoisomers: Stereoselectivity for presynaptic α 2-adrenoceptors (1988) (5)
Pharmacological evidence of an interaction between serotonergic and dopaminergic neurons in the control of prolactin secretion in male rats. (1979) (5)
Effects of some antineoplastic agents on plasma levels of corticosterone, prolactin and thyroid stimulating hormone. (1977) (5)
COMPARISON BETWEEN MONOCONE AND VASE TRAINING SYSTEM ON THE OLIVE CULTIVARS FRONTOI, MORAIOLO AND NOSTRALE DI RIGALI (1994) (5)
Psychotropic drugs: mechanism of action at the neurotransmitter level. (1977) (5)
Cavernous Hemangioma of the Renal Hilum Presenting as an Avascularized Solid Mass (2003) (5)
EFFECTS OF TRAINING SYSTEM ON TREE GROWTH, YIELD AND OIL CHARACTERISTICS IN DIFFERENT OLIVE CULTIVARS (1999) (5)
Holmium Laser Enucleation of the Prostate and Iatrogenic Arteriovenous Fistula Treated by Superselective Arterial Embolization (2016) (5)
Serotonergic involvement in neuroendocrine function. (1980) (4)
[Terramycin in therapy]. (1951) (4)
SELECTION OF TONDA ROMANA AND TONDA DI GIFFONI CROSS POLLINATED HAZELNUT SEEDLINGS (1994) (4)
Receptor involvement in monoamine control of thermoregulatory mechanisms in adult fowls. (1976) (4)
Effects of clonidine on basal and cold-stimulated TSH secretion. (1977) (4)
Effects of single or repeated treatment with several anticholesterolemic compounds on biliary excretion of cholesterol. (1960) (4)
Intraventricular antipyretics and bacterial pyrogen fever. (1976) (4)
Cimetidine and adrenals. (1980) (4)
Release of Immunoreactive lnterleukin-1 -Alpha from Rat Hypothalamic Explants Is Increased by Bacterial Lipopolysaccharide and High KCI Concentrations (1994) (4)
Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression. (2002) (4)
Anticancer drug toxicity via cytokine production: the hydroxyurea paradigm. (1995) (4)
[Pharmacodynamic research on the active principle of Cynara scolimus (1,4-dicaffeiylquinic acid): effect on blood cholesterol values & on triton-induced hypercholesterolemia]. (1957) (3)
Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro. (1995) (3)
Disruptions of the hypothalamo-pituitary-adrenal axis increase anticancer drug lethality in the rat. (1997) (3)
Chronic exposure to vanadate as factor of arterial hypertension in the rat: toxicodynamic mechanisms. (1992) (3)
[Pharmacodynamic research on the active principle of Cynara scolimus (1,4-dicaffeiylquinic acid): effect on choleresis]. (1957) (3)
[Experimental evaluation of 1,4-dicaffeiylquinic acid, the active principle of artichoke]. (1957) (3)
Public health professionals evaluate EURALIM, a European information campaign on diet and nutrition (2000) (3)
Extracellular sodium removal increases release of neuropeptide Y‐like immunoreactivity from rat brain hypothalamic synaptosomes: Involvement of intracellular acidification (1997) (3)
Experimental research on the anti-anginous effects of hydrochlorothiazide and other benzothiadiazine diuretics. (1962) (3)
Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network (2019) (3)
Interleukin-1 alpha and tumour necrosis factor inhibit rat gastric fundus motility in vitro. (1993) (3)
Peptidergic Component of Non‐Adrenergic Non‐Cholinergic Relaxation of the Rat Gastric Fundus a (1998) (3)
On the pulmonary and cardiovascular effects of warfarin sodium. (1959) (3)
Lack of correlation between the antianaphylactic effect of cortisol and its blood concentration. (1979) (3)
The effects of inhibitors of cyclo-oxygenase, lipoxygenase and nitric oxide synthase pathways on the toxicity of hydroxyurea in adrenalectomized rats. (1996) (3)
IIIrd International Congress of Chemotherapy (1964) (3)
Rat brain alpha 2-pre- and postsynaptic receptors are different or differently modulated? (1985) (3)
Adrenal steroid-induced changes in serotonin receptors in rat hippocampus and hypothalamus. (1988) (3)
Effects of vindesine on hypothalamic-pituitary-adrenal axis. (1995) (3)
Etomidate inhibits prolactin release but not through a dopaminergic mechanism (1983) (3)
Hydroxyurea induces vasopressin release and cytokine gene expression in the rat hypothalamus (2006) (3)
Replacement therapy against increased hydroxyurea toxicity in pituitary or adrenal ablated rats. (1985) (3)
Neuropeptide Y increases the inhibitory effects of clonidine on potassium evoked3H-noradrenaline but not3H-5-hydroxytryptamine release from synaptosomes of the hypothalamus and the frontoparietal cortex of the male Sprague-Dawley rat (2005) (3)
Urinary catecholamines and labetalol. (1978) (2)
[Iron accumulation in the liver of patients with thalassemia major assessed with low field strength magnetic resonance: correlation with clinico-instrumental parameters]. (1996) (2)
[Synthesis and pharmacodynamic properties of various lupinane derivatives]. (1969) (2)
21th European Congress on Obesity (ECO2014), Sofia, Bulgaria, May 28-31, 2014: Abstracts (2014) (2)
A possible dissociation of acth effects on the adrenal glands as revealed by aminoglutethimide (1970) (2)
Drugs Acting on Lipid Catabolism and Excretion (1964) (2)
Hydroxyurea influences adrenocortical function in humans (1998) (2)
Stress hormone changes after toxic doses of new anticancer drugs. (1989) (2)
Effect of etomidate enantiomers on CRH-ACTH and prolactin release. (1983) (2)
Role of endogenous nitric oxide in the non-adrenergic non-cholinergic (NANC) relaxation of the rat gastric fundus (1992) (2)
Reduced inhibitory effects of clonidine and neuropeptide Y on 3H-noradrenaline release in synaptosomes of spontaneously hypertensive rats (1989) (2)
[Studies on the metabolism of isonicotinic hydrazide; preliminary report]. (1953) (2)
Physiological relevance of bradykinin as precursor of nitric oxide (1995) (2)
Information resources in toxicology--Italy. (2003) (2)
Alpha 2-adrenoceptor-mediated inhibition of prolactin release in suckling- or fenfluramine-induced hyperprolactinemia. (1991) (2)
Reduced inhibitory effects of clonidine and neuropeptide Y on3H-noradrenaline release from synaptosomes of the medulla oblongata of the spontaneously hypertensive rat (2005) (2)
The effects of (±)‐idazoxan and its stereoisomers on mouse vas deferens motility in vitro. A comparison with yohimbine (1992) (2)
22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts (2015) (2)
Contraceptives brain serotonin and liver tryptophan pyrrolase. (Letter to the editor) (1970) (2)
In vitro testing for lung toxicity. (1993) (2)
Sex-related interactions of cadmium and lead in changing cardiovascular homeostasis and tissue metal levels of chronically exposed rats. (1987) (2)
Nitric oxide and interactions among enkephalinergic, renin-angiotensin and kallikrein-kinin systems in the heart (1992) (2)
Acute central effects of 5,6-dihydroxytryptamine in fowl. (1976) (2)
Faster drug approval: challenges for safety (2016) (2)
Idazoxan inhibits hyperprolactinaemia in ovariectomized estrogen-treated rats. (1991) (2)
On the pharmacology of methoxamine. (1959) (2)
Treatment of lacrimal stenoses obstructions with interventional radiology: immediate and 5-year follow-up results (2008) (2)
Proceedings: Catecholaminergic control of thyroid stimulating hormone (TSH) and adrenocroticotrophic hormone (ACTH) secretion. (1974) (1)
Sonographic findings in cephalothoracopagus-conjoined twins (2006) (1)
Evaluation of biological and agronomic characteristics and oil quality of the middle Italy olive cultivar San Felice [Umbria] (1994) (1)
Brain monoamines and adrenocortical activation. (1968) (1)
Effects of the benzazepine SCH 23390 on prolactin release from isolated pituitary. (1988) (1)
Possible adrenal involvement in hydroxyurea toxicity defense mechanisms. (1985) (1)
Effects of methoxamine on the isolated heart and lungs of guinea pig. (1959) (1)
Different central 5-hydroxytryptamine receptors may modulate crh-acth and prolactin release* (1988) (1)
Determination of optimum pot volume for nursery production of olive trees. (1990) (1)
[THE ANTIEDEMA-ANTIINFLAMMATORY ACTION OF AESCIN AND ITS RELATIONS TO THE ADRENO-HYPOPHYSIAL AXIS]. (1964) (1)
THE ROLE OF CENTRAL NORADRENERGIC AND DOPAMINERGIC NEURONS IN THE CONTROL OF TRH-TSH SECRETION (1979) (1)
Effects of (±) Idazoxan and its stereoisomers on CRH-ACTH release * (1988) (1)
Adrenocortical Activation is Independent from Systemic Toxicity in Long-Term Hydroxyurea Treatment (1986) (1)
Antiemetic and emetic effects of 5-HT3 antagonists in the pigeon: Relevance of serotonergic neurotransmission (1990) (1)
Preliminary investigations on the effects of peach and almond seed skins and cotyledons on germination. (1965) (1)
[CHOLERETIC ACTIVITY OF BENZOTRIAZOLYLALKANOIC ACIDS]. (1965) (1)
Endocrine manipulations may increase hydroxiurea toxicity (1983) (1)
NOREPINEPHRINERGIC CONTROL OF TRF-TSH SECRETION EVOKED BY COLD STRESS**Supported by CNR, Grant (CT 730073204)††Presented by abstract only (1976) (1)
Can pharmacoeconomics and ethics be balanced in drug research and development? (2006) (1)
[The anti-edematous and anti-inflammatory effects of aescin its relation to the hypophyseal-adrenal system]. (1965) (1)
Long-term treatment with clonidine and alpha-receptors in the brain of normotensive rats. (1984) (1)
2.06 – Drug Development (2007) (1)
Potential Therapeutic Effects of Statins in Alzheimer’s Disease (2014) (1)
Labetalol disposition interferes with fluorimetric dosage of catecholamines: in vitro and in vivo trials with enzymatic inhibitors. (1980) (1)
Lack of hypertensive and hyperglycemic effect of diazoxide after intraventricular injection. (1977) (1)
[Modification of endocrine secretions induced by antineoplastic medications]. (1979) (1)
Long-lasting pituitary corticotroph stimulation by vindesine* (1988) (1)
New antibiotics : side effects of modern chemotherapy (1963) (1)
[Mechanism of the hypertensive action of synthetic hypertensin]. (1959) (1)
Contents, Vol. 28, 1979 (1977) (1)
[Antipyretic activity of some new salicylic and gentisinic derivatives]. (1953) (1)
[The effects of dexamethasone and of the combination dexametasone-tetracycline on certain experimental tumors]. (1960) (0)
[Not Available]. (1959) (0)
[Effects of 2-mercaptoethylamine and BAL on experimental uranium poisoning]. (1955) (0)
[Disorders caused by toxicity or intolerance of promazine]. (1958) (0)
[Variability of endocrine disorders in postpartum hypopituitarism]. (1952) (0)
[Pharmacotherapeutic acquisitions of 1961]. (1962) (0)
[Daniel Bovet the scientist]. (1993) (0)
Incremental value of cardiac magnetic resonance in the characterization of patients referred for left ventricular non compaction evaluation (2011) (0)
Contents Vol. 7, 2000 (2000) (0)
[Beta-mercaptoethylamine; pharmacodynamic activity]. (1954) (0)
Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression : 25 years in renal transplantation (2002) (0)
Synthetic resins in the treatment of edemas (1952) (0)
[Physiopathology and therapy of myasthenia]. (1952) (0)
Pericardial Effusion Is a Marker of Increased Mortality in Thalassemia Major Patients (2014) (0)
The role of eicosanoids in cytokine-induced release of CRH-41 from acute rat hypotalamic explants☆ (1992) (0)
[Experimental research on the antihypertensive activity of hydrochlorthiazide]. (1959) (0)
On the mechanism of the anti-hypertensive effect of hydrochlorothiazide. (1961) (0)
[Modified action of ganglioplegics in animals treated with adrenal cortex hormones or with ACTH]. (1956) (0)
Double-blind study of a total liver extract in patients with hepatic dysfunction. (1975) (0)
[Therapeutic possibilities of kanamycin]. (1959) (0)
[Thyroid gland and intestines]. (1952) (0)
These abstracts have been selected for VIEWING only as ePosters and in print. ePosters will be available on Screen A & B throughout the meeting, Print Posters at the times indicated below. Please refer to the PROGRAM for more details (2014) (0)
Prediction of Cardiac Complications in SCD (2019) (0)
[A new ganglioplegic in therapy of hypertension]. (1953) (0)
[Phosphatase acid in brain during subacute tetraethyl lead poisoning]. (1953) (0)
Appendix 1.31: International Union of Toxicology (2005) (0)
[Toxicological effects of prolonged administration of bleomycin in the rat and dog]. (1972) (0)
[Effect of thiamine and its mono- and diphosphoric acid esters on autonomic nervous system and their toxic and analgesic effect]. (1954) (0)
Platelet alpha2-adrenoceptors density in hypercholesterolemia. Relationship with platelet sensitivity to epinephrine (1997) (0)
Voltage-operated Ca2+ channels involved in K+-evoked release of vasoactive intestinal polypeptide from the rat hypothalamus (2001) (0)
Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated (2015) (0)
[Observations on the rooting capacity of 34 cultivars of Olea europea L., treated with B-indolebutiric acid (IBA) and grown in controlled greenhouse] (1975) (0)
Time-course of the effect of alpha-methyl-p-tyrosine on ACTH secretion. (1975) (0)
[Pentothal and the dangers of intravenous anesthesia with barbiturates]. (1953) (0)
PS1572 HEART DISEASE AND PANCREATIC IRON IN THALASSEMIA MAJOR (2019) (0)
[Protective diets and therapeutic possibilities in relation to atherogenous blood lipid disorders]. (1956) (0)
[Catecholamine content of various organs and tissues of mice and dogs treated with hydrochlorothiazide]. (1961) (0)
[Pharmacologic evaluation of liver extracts]. (1966) (0)
[Modification of the histological function of the adrenals in relation to various types of anesthesia]. (1956) (0)
[Effect of tetra-ethyl lead on arterial pressure and respiration]. (1953) (0)
[Gastric diaphragmatic hernia and its anemic syndrome]. (1953) (0)
[Pharmacological research on new salicyl and gentisyl derivatives. I. Toxicity]. (1955) (0)
[Dexamethasone, new synthetic corticoid]. (1959) (0)
[Allergic nephritis]. (1951) (0)
[Pharmacology of the more recent diuretics]. (1961) (0)
[Rectum lipoma: CT diagnosis in a case with intestinal occlusion]. (2001) (0)
[Clinical and statistical considerations on poisoning with carbon monoxide in industry, by accident, and in suicide]. (1953) (0)
[Interference between DL-thioctic acid & methyl bis-(beta-chloroethyl)-amine]. (1959) (0)
[Site of action of isonicotylhydrazide on the nervous system of the frog]. (1952) (0)
[Intrinsic systemic activity of glucocorticoids for topical respiratory use]. (1979) (0)
[Effect of isonicotinic acid hydrazide on sugars; considerations and preliminary research]. (1952) (0)
[Adrenal involvement in tetraethyl lead poisoning]. (1954) (0)
Anti-tremorine effects of the diethylaminoethylester of monoethyl-phenylethylmalonate. (1959) (0)
Immunoreactive interleukin-1β release from the rat gastric fundus is decreased by glucocorticoids and inhibitors of gastric acid secretion (1995) (0)
Vindesine and hypothalamic-hypophyseal-adrenal axis. (1992) (0)
[Posology of isonicotinic acid hydrazide in tuberculous meningoencephalitis in relation to the method of administration and cerebrospinal fluid concentration of the drug]. (1953) (0)
[Activity of 9 alpha-fluoro-16 alpha-hydroxyprednisolone alone or combined with triethylene melamine on various experimental tumors]. (1959) (0)
VIP-thromboxane (TX) A2 balance: A regulatory mechanism in guinea-pig bronchial smooth muscle reactivity (1992) (0)
[Research on the corticomimetic activity of escin]. (1964) (0)
[Adrenocortical changes caused by ganglion blocking drugs]. (1956) (0)
[1-METHYL-LYSERGIC ACID BUTANOLAMIDE AND ADRENOCORTICAL ACTIVATION BY RESERPINE]. (1965) (0)
[Recent acquisitions on vitamin B12]. (1951) (0)
[Megaloblastic anemia in pregnancy]. (1952) (0)
[Different vascular effects of hydrochlorothiazide and an injectable preparation of it]. (1960) (0)
[Study of prostatic carcinoma with ultrasonography and magnetic resonance with "dedicated" surface coil]. (1996) (0)
[Toxoplasmosis in man]. (1950) (0)
[XI National Congress of Hematology, Rome 10-11 May 1953]. (1953) (0)
Beyond poisons and problems: toxicology in Italy. (2008) (0)
[Biologic splitting of isonicotinylhydrazide]. (1954) (0)
[Pharmacotherapeutic advances in 1958. Part II]. (1959) (0)
Chapter 94 – Italy (2009) (0)
[Hypocholesterolemic and hypolipidemic effect of pyridine nucleus compounds: relation between structure and activity and between doses and intensity of action]. (1961) (0)
[Beta-mercaptoethylamine; effects on photosensitization phenomena and on nitrogen mustard and mercury poisoning]. (1954) (0)
[Viomycin in tuberculosis]. (1951) (0)
Adrenocortical Activation by 5-Fluorouracil and its Possible Reversal by Thymidine (1983) (0)
[Adrenal histochemical changes in tetraethyl lead poisoning]. (1954) (0)
Antiviral chemotherapy = Chemotherapie der Viruserkrankungen = Chimothérapie antivirale (1963) (0)
[Current therapy of the gout]. (1953) (0)
[Distribution of lead in acute and subacute tetraethyl lead poisoning in animals]. (1953) (0)
[Pharmacological research on new salicylic and gentisic acid derivatives. IV. Effect on the autonomic nervous system]. (1955) (0)
CHAPTER 25 – Countries (2000) (0)
[Hematologic findings in subacute tetraethyl lead poisoning]. (1953) (0)
[21-hydroxypregnandione and diuresis]. (1956) (0)
[Considerations on the most recent amebacides]. (1951) (0)
[Pharmacotherapeutic advances in 1958. Part I]. (1959) (0)
[The protective action of aescin against cold stress in adrenalectomized rats]. (1965) (0)
[Total hypophysectomy and cancer]. (1953) (0)
[The action of drugs permeabilizing and antipermeabilizing the hemoencephalic barrier on the toxic action of isonicotylhydrazide]. (1952) (0)
Olive mechanical harvesting in trees trained to vase and monocone systems and evaluation of two harvesting yards for harvesting residue olives on the trees [Umbria] (1995) (0)
Platelet α2-adrenergic receptors density in hypercholesterolemia. Relationship with platelet sensitivity to epinephrine (1997) (0)
[On technic in the study and determination of isonicotinic hydrazide and its degradation products in biological fluids]. (1953) (0)
On the antihistamine activity of phloxin. (1958) (0)
[Possibilities and limitations of use of natural and synthetic glucocorticoids]. (1956) (0)
[Pharmacological aspects and clinical importance of a new diuretic, chlorothiazide]. (1958) (0)
[Arginine action on ammonium salt and isoniazid poisoning]. (1956) (0)
Vasoactive intestinal polypeptide- and peptide histidine isoleucine-like immuno-reactivity co-release by the rat gastric fundus (1995) (0)
[Clinical data on occupational and accidental poisoning with a dye noir d'enfers]. (1953) (0)
[Pharmacological contributions of 1960]. (1961) (0)
[Modern status of arsenic in the treatment of leukemia]. (1957) (0)
[Effects of 2-mercaptoethylamine in experimental lead acetate and tetraethyl lead poisoning]. (1955) (0)
[Progesterone in therapy of cholecystopathies]. (1953) (0)
[A CHEMOTHERAPEUTIC AGENT WITH INTERESTING CHARACTERISTICS: NALIDIXIC ACID]. (1965) (0)
[Diverse effect of hydrochlorothiazide in relation to the hypotensive activity of reserpine, rescinnamine, syrosingopine, 1, 4-dihydrazino-phthlazine (alone or associated with reserpine), hexamethonium and guanethidine]. (1961) (0)
[Lipotropic action of vitamin B12]. (1952) (0)
[Disseminated neonatal angiomatosis: diagnosis and follow up of a case]. (1996) (0)
1536 – INTERACTION BETWEEN SEROTONINERGIC AND DOPAMINERGIC NEURONS IN THE CONTROL OF PROLACTIN SECRETION IN THE RAT (1978) (0)
[Treatment of cirrhotic ascites by fractional puncture at short intervals]. (1951) (0)
Nephrotoxicity of first generation cephalosporins: considerations on experimental and clinical pharmacology. (1981) (0)
[Drugs in the prevention of the more important social diseases]. (1961) (0)
A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disorders. (2000) (0)
[Effects of chlorothiazide and of hydrochlorothiazide on the hypotensive activity of reserpine]. (1961) (0)
[Effects of various antihypertensive drugs with and without hydrochlorothiazide on the diuresis test]. (1960) (0)
Citokines modulate the release of CRH-41 from rat hypothalamic explants in vitro (1990) (0)
[The procaine test and hepatic diseases]. (1953) (0)
[Behavior of some hypertensive responses in the dog treated in a subacute manner with hydrochlorothiazide]. (1961) (0)
Combined ultrasounds and CEA in preoperative assessment of hepatic metastases from gastrointestinal malignancies (1985) (0)
[ANTI-INFLAMMATORY ACTIVITY OF 2-ALLYLOXY-3-METHYLBENZAMIDE AND THE HYPOPHYSEAL-ADRENAL AXIS]. (1965) (0)
Effects of Ω-conotoxins GVIA and MVIIC on non-adrenergic non-cholinergic relaxation and vasoactive intestinal polypeptide release in the rat gastric fundus (2000) (0)
MRI Prospective Survey on Cardiac and Hepatic Iron in Thalassemia Intermedia Patients Treated with Desferrioxamine, Deferiprone and Deferasirox (2014) (0)
[Influence of benzhydroflumethiazide on the hypotensive effects of reserpine]. (1961) (0)
[A sulfonamide with interesting characteristics: sulfamethoxypyridazine]. (1958) (0)
Subject Index Vol. 28, 1979 (1979) (0)
[Behavior of pyruvemia after isoniazid administration]. (1955) (0)
[The scission products of isonicotylhydrazide do not exert toxic action]. (1952) (0)
[Effect of oxygen on the toxicity of isonicotylhydrazide]. (1952) (0)
Vegetative and productive response of some olive cultivars introduced into a region of central Italy. (2000) (0)
[Subacute tetra-ethyl lead poisoning]. (1953) (0)
[Iproniazid and pharmacological effects on the adrenal cortex and medulla]. (1959) (0)
[Insulin- and reserpine-induced changes of the content of catecholamine, ascorbic acid and cholesterol of the adrenal with or without iproniazid pretreatment]. (1959) (0)
[Pharmacodynamic aspects of 21-hydroxypregnandione (hydroxydione)]. (1956) (0)
2307 – ROLE OF SEROTONINERGIC SYSTEMS ON TSH AND PROLACTIN SECRETION IN RATS (1978) (0)
Physiologic role of the peripheral enkephalinergic system in regulating cardiovascular homeostasis: evidence of interactions with the renin-angiotensin and kallikrein-kinin systems. (1989) (0)
[Some important biological, pharmacological and therapeutic differences between levulose and glucose]. (1958) (0)
[A new hypotensive agent: mecamilamine]. (1958) (0)
[A new antibiotic; erythromycin]. (1952) (0)
[Practical problems of chemo-antibiotic therapy]. (1972) (0)
[Experimental investigations on the existence of an entero-heaptic circle in the case of sulfonamides with prolonged action]. (1963) (0)
[Pharmacodynamics of new salicylic and gentistic derivatives]. (1954) (0)
[Role of computerized tomography in bladder carcinoma treated with simultaneous combined radiotherapy and chemotherapy]. (1996) (0)
Title Page / Index / Addresses of Authors of Lectures and Communications of the 2nd International Symposium of Chemotherapy, Naples 1961 (1963) (0)
[Toxicity of betamethasone esters alone or in combination with anabolics in the newborn rat]. (1967) (0)
[Rauwolfia serpentina and hypertension]. (1953) (0)
[Neuroendocrine effects of antineoplastic chemoantibiotics]. (1978) (0)
[Antabuse and chronic alcoholism]. (1953) (0)
Subject Index Vol. 4, 1997 (1997) (0)
Subject Index Vol. 7, 2000 (2000) (0)
[Is the toxic symptomatology of isonicotylhydrazide referable to secondary indirect actions of the substance?]. (1952) (0)
Antigen challenge and VIP release by guinea-pig lung (1992) (0)
[Pharmacotherapeutic contributions of 1958. Part III. Endocrine system]. (1959) (0)
Talking points. (1991) (0)
The influence of nutritional factors, and of the number of flowers and of their position in the inflorescence on fruit set of olive (1980) (0)
[4-chlorotestosterone: anabolic steroid]. (1958) (0)
Neuroimmunomodulation Editors Induction by Cytokines of the Pattern of Pituitary Hormone 2 Secretion in Infection Impairment of Adrenocortical Function Associated with 14 Increased Plasma Tumor Necrosis Factor-alpha and Interleu- Kin-6 Concentrations in African Trypanosomiasis Release of Immunoreact (0)
Contents Vol. 4, 1997 (1997) (0)
[Intravenous hydrochloric acid in chronic asystole]. (1952) (0)
[On the toxicity by oral route of the isonicotinoylhydrazone of 2-furyl methyl ketone: comparative research with isoniazid]. (1962) (0)
[Biological & clinical characteristics of a new progestational agent]. (1959) (0)
[Concentration of isonicotinic acid hydrazide in cerebrospinal fluid in tuberculous meningitis during therapy with hydrazide, alone and with glutamic acid]. (1953) (0)
Title Page / Index (1963) (0)
[Failure of isoniazid to decrease pyruvic acid in blood]. (1955) (0)
[Concentration of thiamine and its monophosphoric ester in the blood]. (1954) (0)
[Experimental research on the anti-stenocardiac effect of hydrochlorothiazide and some benzothiadiazine diuretics]. (1961) (0)
[Experimental studies on the nephrotoxicity and hepatotoxicity of kanamycin alone and with panthenol]. (1963) (0)
Endocrine glands, neuroendocrinology and animal experimentation (1990) (0)
4095Longitudinal prospective CMR study in pediatric thalassemia major patients (2017) (0)
Increased PlasmaCorticosteroneand Decreased PlasmaThyroid stimulatingHormoneLevels in Rats Treated with Vincristine1 (1977) (0)
Multi-Parametric Cardiac Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Intermedia: A Prospective Multicenter Study (2015) (0)
Release of immunoreactive interleukin-1-alpha from rat hypothalamic explants is increased by bacterial lipopolysaccharide and high KCL concentrations. (1994) (0)
PERIPHERAL NEUROCHEMICAL AND NEUROENDOCRINE MARKERS IN THE EVALUATION OF CNS ACTING DRUGS (1984) (0)
[Pharmacotherapeutic acquisition in 1962]. (1963) (0)
668 – SPECIFIC RECEPTOR MECHANISMS FOR THE HYPERTHERMIC EFFECTS OF PROSTAGLANDIN El AND E2 (1977) (0)
524Genotypic groups as risk factor for cardiac MR abnormalities and complications in thalassemia major (2019) (0)
Multimodality Imaging for Diagnosis and Characterization of a Cardiac Hydatid Cyst (2020) (0)
[Therapy of myocardial infarct]. (1953) (0)
Percutaneous nephrolitotomy treatment of renal stone: Two steps tecnique. (2002) (0)
Anticancer Drug Toxicity in the Absence of Hypophyseal or Adrenal Secretion (1988) (0)
[Destruction of isonicotinylhydrazide in parenchymas of various organs]. (1953) (0)
Kallikrein-kinin,enkephalin, renin-aldosterone and catecholamine systems in the vanadate (as vanadyl)-induced arterial hypertension. (1992) (0)
Characterization of neuropeptide Y-like immunoreactivity release from rat hypothalamic synaptosomes (1995) (0)
2315 – CHRONIC DEPLETION OF BRAIN SEROTONIN (5HT) AND THYROTROPIN (TSH) SECRETION (1978) (0)
[Effect of isonicotyl hydrazide on certain ferments]. (1952) (0)
[Synthesis & pharmacodynamic characteristics of new diethylaminoethyl esters of substituted malonic acid]. (1958) (0)
[Pharmacological research on new salicylic and gentisic acid derivatives. III. Blood pressure and respiratory changes]. (1955) (0)
[Pharmacological research on new salicyl and gentisyl derivatives. II. Antipyretic, analgesic, hyaluronidase-inhibiting, anti-permeability and anti-exudative activity]. (1955) (0)
[General pharmacology of bleomycin in various animal species]. (1972) (0)
[Effects of chlorothiazide and hydrochlorothiazide on the hypotensive activity of reserpine]. (1960) (0)
[Possibility of chemotherapy for neoplasms with pyrimidine & purine antagonists]. (1957) (0)
[Deplasmatized erythrocyte transfusions]. (1953) (0)
[The specific biological activity of the glucocorticoid betamethasone 17,21-dipropionate]. (1980) (0)
[Anticoagulant therapy: present and future indications]. (1951) (0)
[Vitamin B12 and pteroylglutamic acids in megaloblastic anemia]. (1952) (0)
[Variation of some biological indices for tetra-ethyl lead poisoning]. (1953) (0)
[Phenylindanedione as an anti-coagulant]. (1953) (0)
[Treatment of hypertension]. (1952) (0)
Blood cholesterol levels after medullo-adrenalectomy in dogs. (1961) (0)
[Problems of interactions in chemo-antibiotic combinations]. (1974) (0)
[ADRENAL CORTEX CHANGES DUE TO RESERPINE, FORMALIN AND PIROMEN IN ANIMALS PRETREATED OR NOT WITH IPRONIAZID]. (1963) (0)
[Recent acquisitions in antidiabetic sulfanilyl-ureas]. (1957) (0)
[Estrogenic activity and pharmacological characteristics of 2-(3-hydroxy-1,3,5(10)-estratriene-17-one)-isobutyric acid]. (1954) (0)
[Vascular actions of hydrochlorothiazide and other benzothiadiazine diuretics (with special reference to their anthypertensive and antistenocardiac activities)]. (1961) (0)
[Heparin in hypertension]. (1953) (0)
[Occupational poisoning in aeronautics]. (1953) (0)
Carbon monoxide and nitric oxide control interleukin-1 production and release in rat brain (1998) (0)
[Effect of tetra-ethyl lead on the autonomic nervous system]. (1953) (0)
[Experimental studies of the interference between ATP and strophanthin]. (1956) (0)
[Possibilities of prevention of adrenal cortical modifications by means of a neuroplegic combination in cold exposure]. (1957) (0)
Corrigendum to ‘Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro’ [Eur. J. Pharmacol. 275 (1995) 31–37] (1995) (0)
[Experimental and clinical importance of pantothenates of streptomycin, dihydrostreptomycin and viomycin]. (1958) (0)
[PHARMACOTHERAPEUTIC ACQUISITIONS FOR 1963-64]. (1965) (0)
[Warfarin and coronary and peripheral circulation]. (1959) (0)
[A new choleretic drug: 1,4-dicaffeyl-quinic acid]. (1958) (0)
[Life in imperial Rome: new data from recent excavations in Suburbium]. (2006) (0)
[Pharmacotherapeutic acquisitions in 1961. I]. (1962) (0)
[Etiopathogenetic clinical and therapeutic orientations in brucellosis]. (1950) (0)
[Pharmacodynamic research on the active principle of Cynara scolimus (1,4-dicaffeiylquinic acid): effect of diuresis]. (1957) (0)
[Phenylbutazone; pharmacology; therapeutic aspects; toxic symptomatology and sensitivity]. (1955) (0)
[Effect of antirheumatic drugs on the adrenal gland]. (1954) (0)
[Characteristics of a new neuroleptic: levomepromazine]. (1959) (0)
[Effect of B2 on the toxic symptomatology of isonicotylhydrazide]. (1952) (0)
[Salt-losing nephritis]. (1953) (0)
[Present-day problems in pernicious anemia; pathogenesis of pernicious anemia and vitamin B12]. (1951) (0)
Endocrine Changes and 5-Hydroxytryptamine Receptor Subtypes (1990) (0)
[Pharmacotherapeutic acquisitions in 1961. II]. (1962) (0)
[Recent therapy in Parkinson's disease]. (1951) (0)
[Blood coagulation in cardiac decompensation, before and after therapy]. (1951) (0)
[Modified barbiturate anesthesia in excess and deficiency of vitamin B1]. (1954) (0)
201 – CENTRAL CATECHOLAMINERGIC REGULATION OF TRF-TSH SECRETION (1977) (0)
Abstracts of the Belgian Society of Fundamental and Clinical Physiology and Pharmacology (Autumn Meeting), 20 November 1993, Brussels, Belgium (2004) (0)
Lack of stress-induced neuroendocrine changes after prolonged drinking of acid water in the rat. (1989) (0)
[Pharmacotherapeutic acquisitions of 1961]. (1962) (0)
[Isonicotylhydrazide, polyphenoloxidase and copper]. (1953) (0)
[Pharmacotherapeutic acquisitions of 1961]. (1962) (0)
[Apropos of the hypocholesterolemic effects of nicotinic acid. Experimental investigations of such a compound and of inositol hexanicotinate]. (1961) (0)
[Presumed corticotrophic action of the antirheumatic drugs]. (1955) (0)
[Histopathological findings in subacute tetraethyl lead poisoning]. (1953) (0)
[Interference between isonicotyl hydrazide and sugar]. (1952) (0)
[Recent acquisitions on heparin]. (1950) (0)
[Use of isoniazid in leprosy]. (1953) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paolo Preziosi?

Paolo Preziosi is affiliated with the following schools:

University of Rome Tor Vergata

Paolo Preziosi's Academic­Influence.com Rankings

Why Is Paolo Preziosi Influential?

Paolo Preziosi's Published Works

Published Works

What Schools Are Affiliated With Paolo Preziosi?

Paolo Preziosi's AcademicInfluence.com Rankings